In all tumor cells investigated the ICAM-1 antibody significantly suppressed the celecoxib-induced tumor cell lysis by LAK cells when compared to cells treated with vehicle and isotype control antibody, respectively (Fig. 5A–5C). The gene discussed is ICAM1; the disease is neoplasm.